ETF DAILY NEWS
Marion Mccourt Sells 1,137 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) EVP Marion Mccourt sold 1,137 shares of the stock in a transaction on Monday, July 1st. The shares were sold at an average price ...
6 days ago
1834 Investment Advisors Co. Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
1834 Investment Advisors Co. cut its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.0% in the 1st quarter, according to its most recent filing with the ...
3 days ago
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Tokio Marine Asset Management Co. Ltd.
Tokio Marine Asset Management Co. Ltd. boosted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.9% in the first quarter, according to its most recent ...
2 days ago
Maryland State Retirement & Pension System Has $7.31 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Maryland State Retirement & Pension System boosted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the 1st quarter, according to the company ...
5 days ago
Investor's Business Daily
Swing Trading Regeneron Stock Shows How To Bob And Weave
Benzinga
...Firm Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals, Inc. - REGN - Regeneron Pharmaceuticals (NASDAQ:...
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ:REGN). Such investors are advised to
View all
regeneron.com
More on Yahoo Finance